Business Information
The group operates in three segments: life sciences, health and proteomics. Life sciences segment consists of supplying pharmaceuticals, medical devices and supplies. The products and services offered in this segment include advanced analytical equipment, medical isotopes and pharmaceutical contract research services. In the health segment, the group provides health care services to consumers. The services offered in this segment include clinical laboratory testing and distribution of medical products. In the proteomics segment, the group focuses on research and development of proteomic-enabled drug discovery. Customers include manufacturers of medical products and health care institutions. The company operates in Canada, the United States, Europe and Asia. The services offered in this segment include capabilities in proteomics systems, technology, drug design and screening. Life sciences accounted for 60% of 2002 revenues; health, 40% and proteomics, nominal.
|
|
Name |
Title
|
Email
|
| John Mayberry | Chmn. | N/A | | Andrew Boorn | Pres. - MDS Analytical Technologies | N/A | | David Spaight | Pres. - MDS Pharma Services | N/A | | Hans Thunem | Pres. | N/A | | Steven West | Pres. - MDS Nordion | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 1,017,222 | 123,137 | | 2005 | 1,265,799 | 26,353 | | 2004 | 1,448,068 | 22,164
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
